NVDA231.50+0.44% BTC/USD82,942.24+1.53% TSLA387.52+3.34% EUR/USD1.12-0.13% GOLD4,209.30+1.26% ISP.MI6.12+0.94% RACE.MI347.85+1.47% AAPL333.70-1.97% S&P 500 ETF777.06+0.40%
TradeGPT TradeGPT AI
Google Play Get App (Free)

Johnson & Johnson (JNJ)

Healthcare & Pharma • Quantitative Market Data & AI Analytics

RSI(14): 43.0 🔒 AI Forecast in App
258.30
+1.81 (+0.71%) 24h | +1.16% 7D | Latest Active Session
JNJ Interactive Historical Chart (1Y Daily)
Historical charts are for educational visualization only. Drag or pinch to inspect historical candles
Open
255.09
Prev. Close
256.48
Day High
259.93
Day Low
254.99
52-Week High
281.07
52-Week Low
180.59
Session Volume
638.4K
30D Volatility (HV)
17.0%
JNJ Relative Strength Index (RSI 14) Neutral Zone (30-70)
43.00
0 (Oversold <30) 50 (Neutral) 100 (Overbought >70)
JNJ MACD (12, 26, 9) Level Daily Oscillator
-2.723
Signal Line (9)
-1.475
MACD Histogram
-1.248
Volume & Price Highlights APP Fibonacci Pivot Points APP Chart Pattern Detector APP

Market Ranges & Volume

Volume (Vs History) 4.7M
24.8M
Daily Range 254.99
259.93
52-Week Range 180.59
281.07
Quantitative Technical Ratings & AI Signals (JNJ) PREMIUM / ULTRA IN APP
Metric / IndicatorCurrent ReadingAI Action Verdict
RSI (14) Relative Strength 43.00 🔒 Unlock AI Verdict
MACD (12, 26, 9) Level / Signal -2.723 / -1.475 🔒 Unlock AI Verdict
Bollinger Bands (20, 2) & EMA (50/200) 247.96 - 268.63 BULLISH TREND
AI News Sentiment & Momentum Score 82.5 / 100 High Accumulation
AI Hybrid Probability & 30D Target Range 242.80 - 289.29 STRONG BUY

Unlock Full AI Analysis & Statistical Projections for JNJ

You are viewing raw mathematical RSI (43.0) and MACD (-2.723) computations. To unlock AI interpretation, Bullish/Bearish ratings, Bollinger Bands, Executive Insider Trades, and 30-Day Statistical Trend Charts for Johnson & Johnson, download the TradeGPT Android app.

Google Play Download on Google Play

About Johnson & Johnson (JNJ)

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Read more

Latest JNJ HeadlinesAI Sentiment Scored

J&J Stock Ahead of Q3 Earnings: Should You Buy, Sell or Hold? - Zacks Investment Research
Zacks Investment Research • Oct 09, 2026
Sentiment in App
Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Yahoo Finance • Oct 05, 2026
Sentiment in App
Fund Update: 51,822 JOHNSON & JOHNSON (JNJ) shares added to SAPIENT CAPITAL LLC portfolio - Quiver Quantitative
Quiver Quantitative • Oct 08, 2026
Sentiment in App
JNJ Stock Advances After Hours On $5.5B Proposal To Resolve Talc Litigation - Stocktwits
Stocktwits • Oct 07, 2026
Sentiment in App

Related Instruments

BMY
Bristol-Myers
TMUS
T-Mobile
COPPER
Copper
LTCUSD
Litecoin
AVGO
Broadcom